Association of polycystic ovary syndrome with cardiovascular risk factors

被引:17
作者
Akram, Tanzeela [1 ]
Hasan, Shahid [2 ]
Imran, Muhammad [1 ]
Karim, Asima [1 ]
Arslan, Muhammad [3 ]
机构
[1] Univ Hlth Sci, Dept Physiol & Cell Biol, Lahore 54600, Pakistan
[2] CMH Lahore Med Coll, Dept Physiol, Lahore, Pakistan
[3] Univ Punjab, Dept Zool, Lahore, Pakistan
关键词
Insulin resistance; polycystic ovary syndrome; infertility; amenorrhea; INSULIN-RESISTANCE; NONOBESE PATIENTS; SPONTANEOUS-ABORTION; LUTEINIZING-HORMONE; DENSITY-LIPOPROTEIN; METABOLIC SYNDROME; HOMEOSTASIS MODEL; YOUNG-WOMEN; PREVALENCE; HYPERANDROGENISM;
D O I
10.3109/09513590903159565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Polycystic ovary syndrome (PCOS), also clinically known as Stein-Leventhal syndrome, is an endocrine disorder that affects 5-10% of women. Objective. To evaluate the risk factors for developing early onset of cardiovascular disease (CVD) in young patients with PCOS from our local population. Design. Case-control study. Methods. Fifty women with PCOS selected by history and transvaginal ultrasounds and 30 age-matched healthy women (controls). The case subjects and controls were further divided into two age categories comprising of equal number of subjects, of 20-29 and 30-39 years of age. The subjects underwent a detailed medical history, general physical examination, systolic (SBP) and diastolic blood pressures (DBP). Fasting blood samples were analyzed for glucose, insulin, triacylglycerides (TAG), total cholesterol, high density lipoprotein-C (HDL-C), low density lipoprotein-C (LDL-C), follicle-stimulating hormone (FSH), and luteinizing hormone (LH). Results. Women with the PCOS had significantly higher mean arterial pressure (MAP), serum TAG, LDL-C, insulin, and LH levels when compared with the age-matched control subjects. No significant differences were observed between serum cholesterol, glucose, and FSH levels between cases and controls. However, no marked differences were observed in biochemical parameters between the two age groups of PCOS patients. Conclusions. Younger women with PCOS are equally at risk of developing CVD as older women.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 58 条
[21]   Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study [J].
Glueck, CJ ;
Phillips, H ;
Cameron, D ;
Sieve-Smith, L ;
Wang, P .
FERTILITY AND STERILITY, 2001, 75 (01) :46-52
[22]   The importance of insulin resistance in polycystic ovary syndrome [J].
Goodarzi, MO ;
Korenman, SG .
FERTILITY AND STERILITY, 2003, 80 (02) :255-258
[23]   The homeostasis model in the San Antonio Heart Study [J].
Haffner, SM ;
Miettinen, H ;
Stern, MP .
DIABETES CARE, 1997, 20 (07) :1087-1092
[24]   Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome [J].
Hart, R ;
Hickey, M ;
Franks, S .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) :671-683
[25]   Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: Evidence from GnRH agonist and human chorionic gonadotropin stimulation testing [J].
Ibanez, L ;
Hall, JE ;
Potau, N ;
Carrascosa, A ;
Prat, N ;
Taylor, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :4103-4107
[26]   EVIDENCE FOR INSULIN RESISTANCE IN NONOBESE PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
JIALAL, I ;
NAIKER, P ;
REDDI, K ;
MOODLEY, J ;
JOUBERT, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (05) :1066-1069
[27]   The prevalence of polycystic ovaries in women with infertility [J].
Kousta, E ;
White, DM ;
Cela, E ;
McCarthy, MI ;
Franks, S .
HUMAN REPRODUCTION, 1999, 14 (11) :2720-2723
[28]   The current status of polycystic ovary syndrome [J].
Kovacs, G ;
Wood, C .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2001, 41 (01) :65-68
[29]   Predictors of endothelial dysfunction in young women with polycystic ovary syndrome [J].
Kravariti, M ;
Naka, KK ;
Kalantaridou, SN ;
Kazakos, N ;
Katsouras, CS ;
Makrigiannakis, A ;
Paraskevaidis, EA ;
Chrousos, GP ;
Tsatsoulis, A ;
Michalis, LK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09) :5088-5095
[30]   Polycystic ovary syndrome and cardiovascular disease: A premature association? [J].
Legro, RS .
ENDOCRINE REVIEWS, 2003, 24 (03) :302-312